Prevention of sudden cardiac death and implantable cardioverter defibrillators: Understanding the competitive risk!

被引：1

作者：

Rischard, Julien ^{[1
]}

Narayanan, Kumar ^{[2
]}

Garcia, Rodrigue ^{[3
]}

Marijon, Eloi ^{[4
]}

机构：

[1] Hop Europeen Georges Pompidou, Dept Cardiol, Unite Rythmol, F-75015 Paris, France

[2] Medicover, Cardiol Dept, Hyderabad, India

[3] CHU Poitiers, Unite Rythmol, F-86000 Poitiers, France

[4] Hop Europeen Georges Pompidou, Dept Cardiol, Unite Rythmol, 20 Rue Leblanc, F-75908 Paris 15, France

来源：

PRESSE MEDICALE | 2019年 / 48卷 / 12期

关键词：

HEART-FAILURE;

D O I：

10.1016/j.lpm.2019.09.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sudden cardiac death represents a major public health issue, with up to 50% of the cardiovascular mortality. Coronary artery disease and dilated cardiomyopathy both represent almost 90% of sudden cardiac death burden. Primary prevention using implantable cardioverter defibrillator relies, in this population, on the left ventricle ejection fraction simple measurement. In this paper, we aim to discuss in which extent a better understanding of competing risk situation may help for a better patient selection and eventually for optimizing primary prevention using implantable cardioverter defibrillator.

引用

页码：1401 / 1405

页数：5

共 8 条

[1] 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary [J].

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (14) :1677-1749

[2] Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators [J].

Bilchick, Kenneth C. ;

Wang, Yongfei ;

Cheng, Alan ;

Curtis, Jeptha P. ;

Dharmarajan, Kumar ;

Stukenborg, George J. ;

Shadman, Ramin ;

Anand, Inder ;

Lund, Lars H. ;

Dahlstroem, Ulf ;

Sartipy, Ulrik ;

Maggioni, Aldo ;

Swedberg, Karl ;

O'Conner, Chris ;

Levy, Wayne C. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (21) :2606-2618

[3] Risk stratification for primary implantation of a Cardioverter-Defibrillator in patients with ischemic left ventricular dysfunction [J].

Goldenberg, Ilan ;

Vyas, Anant K. ;

Hall, W. Jackson ;

Moss, Arthur J. ;

Wang, Hongyue ;

He, Hua ;

Zareba, Wojciech ;

McNitt, Scott ;

Andrews, Mark L. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) :288-296

[4]

Hjalmarson Å, 1999, LANCET, V353, P2001

[5] Frequency and Determinants of Implantable Cardioverter Defibrillator Deployment Among Primary Prevention Candidates With Subsequent Sudden Cardiac Arrest in the Community [J].

Narayanan, Kumar ;

Reinier, Kyndaron ;

Uy-Evanado, Audrey ;

Teodorescu, Carmen ;

Chugh, Harpriya ;

Marijon, Eloi ;

Gunson, Karen ;

Jui, Jonathan ;

Chugh, Sumeet S. .

CIRCULATION, 2013, 128 (16) :1733-1738

[6] 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death [J].

Priori, Silvia G. ;

Blomstrom-Lundqvist, Carina ;

Mazzanti, Andrea ;

Blom, Nico ;

Borggrefe, Martin ;

Camm, John ;

Elliott, Perry Mark ;

Fitzsimons, Donna ;

Hatala, Robert ;

Hindricks, Gerhard ;

Kirchhof, Paulus ;

Kjeldsen, Keld ;

Kuck, Karl-Heinz ;

Hernandez-Madrid, Antonio ;

Nikolaou, Nikolaos ;

Norekval, Tone M. ;

Spaulding, Christian ;

Van Veldhuisen, Dirk J. .

EUROPACE, 2015, 17 (11) :1601-1687

[7]

Waldmann V, 2017, Ann Cardiol Angeiol (Paris), V66, P230, DOI 10.1016/j.ancard.2017.06.002

[8]

Waldmann V, 2017, ENCY MED CHIR

← 1 →